Omaha, NE, United States of America

Shashank Dravid

This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shashank Dravid. Retrieved from https://idiyas.com/inventor/shashank-dravid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shashank Dravid: Innovator in Pain Treatment

Introduction

Shashank Dravid is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of pain management through his innovative research and development of pharmaceutical compositions.

Latest Patents

Dravid holds a patent for "Methods and compositions for treating pain." This patent provides polypeptides and pharmaceutical compositions that can be useful in treating pain in subjects. Specifically, these polypeptides are designed to address neuropathic and inflammatory pain, showcasing his commitment to improving patient care.

Career Highlights

Shashank Dravid is affiliated with Creighton University, where he continues to advance his research in the medical field. His work focuses on developing effective treatments that can alleviate pain, demonstrating his dedication to innovation in healthcare.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Shashank Dravid's contributions to pain treatment through his patented methods highlight his role as an important figure in medical innovation. His work at Creighton University continues to pave the way for advancements in pain management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…